Literature DB >> 19911991

Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants.

Tran Nguyen Bich Chau1, Nguyen Trong Hieu, Katherine L Anders, Marcel Wolbers, Le Bich Lien, Lu Thi Minh Hieu, Tran Tinh Hien, Nguyen Thanh Hung, Jeremy Farrar, Stephen Whitehead, Cameron P Simmons.   

Abstract

Dengue hemorrhagic fever can occur in primary dengue virus (DENV) infection of infants. The decay of maternally derived DENV immunoglobulin (Ig) G and the incidence of DENV infection were determined in a prospectively studied cohort of 1244 Vietnamese infants. Higher concentrations of total IgG and DENV-reactive IgG were found in cord plasma relative to maternal plasma. Maternally derived DENV-neutralizing and E protein-reactive IgG titers declined to below measurable levels in >90% of infants by 6 months of age. In contrast, IgG reactive with whole DENV virions persisted until 12 months of age in 20% of infants. Serological surveillance identified 10 infants with asymptomatic DENV infection for an incidence of 1.7 cases per 100 person-years. DENV-neutralizing antibodies remained measurable for > or = 1 year after infection. These results suggest that whereas DENV infection in infants is frequently subclinical, there is a window between 4 and 12 months of age where virion-binding but nonneutralizing IgG could facilitate antibody-dependent enhancement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911991      PMCID: PMC4340501          DOI: 10.1086/648407

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

2.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

3.  Assessment of the factors associated with flavivirus seroprevalence in a population in Southern Vietnam.

Authors:  L M Bartley; H Carabin; N Vinh Chau; V Ho; C Luxemburger; T T Hien; G P Garnett; J Farrar
Journal:  Epidemiol Infect       Date:  2002-04       Impact factor: 2.451

4.  A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

Authors:  R R Graham; M Juffrie; R Tan; C G Hayes; I Laksono; C Ma'roef; K R Porter; S B Halstead
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

5.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.

Authors:  S C Kliks; S Nimmanitya; A Nisalak; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

6.  Volume replacement in infants with dengue hemorrhagic fever/dengue shock syndrome.

Authors:  Thanh Hung Nguyen; Trong Lan Nguyen; Huan-Yao Lei; Yee-Shin Lin; Bich Lien Le; Kao-Jean Huang; Chiou-Feng Lin; Quang Ha Do; Thi Que Huong Vu; Thi My Lam; Trai-Ming Yeh; Jyh-Hsiung Huang; Ching-Chuan Liu; Scott B Halstead
Journal:  Am J Trop Med Hyg       Date:  2006-04       Impact factor: 2.345

7.  Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.

Authors:  Cameron P Simmons; Tran Nguyen Bich Chau; Tran Thi Thuy; Nguyen Minh Tuan; Dang Minh Hoang; Nguyen Thanh Thien; Le Bich Lien; Nguyen Thien Quy; Nguyen Trong Hieu; Tran Tinh Hien; Catriona McElnea; Paul Young; Steve Whitehead; Nguyen Thanh Hung; Jeremy Farrar
Journal:  J Infect Dis       Date:  2007-06-19       Impact factor: 5.226

8.  Transplacentally transferred maternal-infant antibodies to dengue virus.

Authors:  Veerachai Watanaveeradej; Timothy P Endy; Rudiwilai Samakoses; Angkool Kerdpanich; Sriluck Simasathien; Napuschon Polprasert; Chanchai Aree; David W Vaughn; Cynthia Ho; Ananda Nisalak
Journal:  Am J Trop Med Hyg       Date:  2003-08       Impact factor: 2.345

9.  Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.

Authors:  Katie B Anderson; Supamit Chunsuttiwat; Ananda Nisalak; Mammen P Mammen; Daniel H Libraty; Alan L Rothman; Sharone Green; David W Vaughn; Francis A Ennis; Timothy P Endy
Journal:  Lancet       Date:  2007-04-28       Impact factor: 79.321

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  64 in total

1.  Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo.

Authors:  Katherine L Williams; Wahala M P B Wahala; Susana Orozco; Aravinda M de Silva; Eva Harris
Journal:  Virology       Date:  2012-04-25       Impact factor: 3.616

2.  Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.

Authors:  Priscila M S Castanha; Cynthia Braga; Marli T Cordeiro; Ariani I Souza; Claudeir D Silva; Celina M T Martelli; Willem G van Panhuis; Eduardo J M Nascimento; Ernesto T A Marques
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

3.  Decay and persistence of maternal dengue antibodies among infants in Bangkok.

Authors:  Willem G van Panhuis; Christine Luxemburger; Krisana Pengsaa; Kriengsak Limkittikul; Arunee Sabchareon; Jean Lang; Anna P Durbin; Derek A T Cummings
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

4.  Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.

Authors:  Angela M Fowler; William W Tang; Matthew P Young; Anila Mamidi; Karla M Viramontes; Melanie D McCauley; Aaron F Carlin; Robert T Schooley; Jesica Swanstrom; Ralph S Baric; Jennifer Govero; Michael S Diamond; Sujan Shresta
Journal:  Cell Host Microbe       Date:  2018-11-14       Impact factor: 21.023

5.  Contribution of dengue fever to the burden of acute febrile illnesses in Papua New Guinea: an age-specific prospective study.

Authors:  Nicolas Senn; Dagwin Luang-Suarkia; Doris Manong; Peter Max Siba; William John Hannan McBride
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

6.  Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice.

Authors:  Smita Jaiswal; Pamela Pazoles; Marcia Woda; Leonard D Shultz; Dale L Greiner; Michael A Brehm; Anuja Mathew
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

Review 7.  Dengue: knowledge gaps, unmet needs, and research priorities.

Authors:  Leah C Katzelnick; Josefina Coloma; Eva Harris
Journal:  Lancet Infect Dis       Date:  2017-02-07       Impact factor: 25.071

8.  The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.

Authors:  Martina Beltramello; Katherine L Williams; Cameron P Simmons; Annalisa Macagno; Luca Simonelli; Nguyen Than Ha Quyen; Soila Sukupolvi-Petty; Erika Navarro-Sanchez; Paul R Young; Aravinda M de Silva; Félix A Rey; Luca Varani; Stephen S Whitehead; Michael S Diamond; Eva Harris; Antonio Lanzavecchia; Federica Sallusto
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

9.  Clinical and virological features of Dengue in Vietnamese infants.

Authors:  Tran Nguyen Bich Chau; Katherine L Anders; Le Bich Lien; Nguyen Thanh Hung; Lu Thi Minh Hieu; Nguyen Minh Tuan; Tran Thi Thuy; Le Thi Phuong; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Jeremy J Farrar; Stephen S Whitehead; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

10.  CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice.

Authors:  Raphaël M Zellweger; William E Eddy; William W Tang; Robyn Miller; Sujan Shresta
Journal:  J Immunol       Date:  2014-09-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.